Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/2012
04/25/2012CN101830985B 肠出血性大肠杆菌O157:H7Tir与Tccp的重组蛋白 EHEC O157: H7Tir and Tccp recombinant protein
04/25/2012CN101829110B 穿心莲内酯衍生物在制备抗hiv药物中的用途 Andrographolide derivatives in the manufacture of a medicament for anti-hiv
04/25/2012CN101818132B Construction of chimeric rabies strain rLEP333Q-L(H) and research on biological function thereof
04/25/2012CN101810541B 一种消毒沐浴露 A disinfecting shower gel
04/25/2012CN101791338B 抗流感药物、其制备方法及应用 Anti-influenza drug, and its preparation method and application
04/25/2012CN101747345B 无定形头孢地嗪钠及其制备方法和含有该无定形的药物组合物 Sodium amorphous cefodizime its preparation method and containing the amorphous pharmaceutical composition
04/25/2012CN101745104B 含有复合佐剂的结核亚单位疫苗 Tuberculosis subunit vaccine containing a complex adjuvant
04/25/2012CN101732392B 一种中药大青叶的质量检测方法 Quality detection method of Chinese medicine Folium
04/25/2012CN101717450B 抗菌肽lfb-me及其制备方法 Antimicrobial peptides lfb-me and its preparation method
04/25/2012CN101700216B 一种天然芳香水剂及其制备方法和应用 A natural aromatic agent and its preparation method and application
04/25/2012CN101503457B 柱层析peg与干扰素类似物蛋白氮端定点偶联方法及其产物 Column chromatography peg interferon analog protein nitrogen end point coupling methods and their products
04/25/2012CN101481382B 27-去甲西罗莫司的制备方法 A 27- to preparation of sirolimus
04/25/2012CN101442996B 抗微生物剂以及抗微生物组合物 The antimicrobial agents and antimicrobial composition
04/25/2012CN101366510B 一种具有预防感冒的泡制饮品 Having a drink brewed prevent colds
04/25/2012CN101343303B 一种治疗艾滋病的药物化合物及其制备方法和应用 A method of treating AIDS drug compound and its preparation method and application
04/25/2012CN101252925B 以逆转录酶抑制剂和美度铵为基础的药物组合物 With reverse transcriptase inhibitors and beauty of the ammonium-based pharmaceutical composition
04/25/2012CN101181548B 一种含有天然抗菌剂的药用或保健组合物 Pharmaceutical or health care composition containing a natural antimicrobial agent
04/25/2012CN101181277B 含核苷酸类似物的组合物及其合成方法 Compositions containing nucleotide analogs and synthetic methods
04/25/2012CN101102794B 抗sars-冠状病毒的组合物及其应用 Anti-sars- coronavirus composition and application
04/25/2012CN101069744B 流感疫苗组合物 Influenza vaccine composition
04/24/2012US8163806 Controlled release of biologically active compounds from multi-armed oligomers
04/24/2012US8163805 Small molecule antagonists of Bcl-2 family proteins
04/24/2012US8163776 Immunomodulation by administering thione-forming dithiobis-heterocyclic compound, increased natural killer cell activity, expansion of NK cell population, decreased B cell population, decreased antibody production
04/24/2012US8163762 Purine derivatives having, in particular, anti-proliferative properties, and their biological uses
04/24/2012US8163718 Nucleoside analogues containing phosphonate or phosphonamide groups
04/24/2012US8163705 Glycolipid and use thereof
04/24/2012US8163536 Apparatus for use in the propagation of pluripotent cells
04/24/2012US8163528 Nucleic acid molecules encoding thymidine kinase fusion proteins
04/24/2012US8163297 Live attenuated aldolase-negative bacterial vaccine
04/24/2012US8163293 Modified Vaccinia Virus Ankara for the vaccination of neonates
04/24/2012CA2645467C Pyridine derivative having anti-helicobacter pylori activity
04/24/2012CA2539256C Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells
04/24/2012CA2499322C Benzodiapine derivatives and pharmaceutical compositions containing them
04/24/2012CA2452447C Antagonistic anti-htnfsf13b human antibodies
04/24/2012CA2433807C Hydrophobic polyamine analogs and methods for their use
04/24/2012CA2433582C Peptides having inhibiting activity on the production of nitric oxide
04/24/2012CA2431557C Derivatives of streptogramins, their preparation and compositions containing them
04/24/2012CA2425599C Fumaric acid amides
04/24/2012CA2239072C Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
04/19/2012WO2012051492A2 Compounds and methods for inhibiting hiv latency
04/19/2012WO2012051204A2 Antimicrobial formulations that aid in wound healing
04/19/2012WO2012050513A1 Method for identifying a risk of cardiovascular disease by analysing oral microbiota
04/19/2012WO2012050229A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses
04/19/2012WO2012050193A1 Ebola virus liposome vaccine
04/19/2012WO2012050162A1 Cellular life span extending agent, and telomerase activator
04/19/2012WO2012050151A1 Acylbenzene derivative
04/19/2012WO2012049366A1 Norovirus capsid and rotavirus vp6 protein for use as combined vaccine
04/19/2012WO2012049327A2 Pesticidal mixtures
04/19/2012WO2012049161A1 3 -amino- pyrazole derivatives useful against tuberculosis
04/19/2012WO2012048653A1 Long-life interferon fusion protein and use thereof
04/19/2012WO2012048553A1 Escherichia coli tolc antigen, antibody and use thereof
04/19/2012WO2012048455A1 Transdermal absorption patch of antiviral drug and its preparation method
04/19/2012WO2012048430A1 Affinity-conjugated nucleoprotein-papaya mosaic virus-like particles and uses thereof
04/19/2012WO2012048421A1 Hepatitis c inhibitor compounds
04/19/2012WO2012015270A3 Permissive cell line to the porcine reproductive and respiratory syndrome virus
04/19/2012WO2012006596A3 Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
04/19/2012WO2011163533A4 One step removal of selected molecules from body fluid and tissue
04/19/2012WO2011158176A3 Gold complexes for use in the treatment of cancer
04/19/2012WO2011155727A3 Method for preventing and treating infection caused by salmonella choleraesuis or salmonella dublin
04/19/2012WO2011153502A3 Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them
04/19/2012WO2011153460A3 Therapeutic amoeba and uses thereof
04/19/2012WO2011150127A3 Novel systems, vectors, and methods for delivery of biomolecules to eukaryotic cells
04/19/2012WO2011133963A3 Tyrosine-based prodrugs of antiviral agents
04/19/2012WO2011133681A3 Low/high dose probiotic supplements and methods of their use
04/19/2012WO2011126856A3 Herpes simplex virus mutant icp0
04/19/2012WO2011116094A3 Live attenuated chimeric porcine circovirus vaccine
04/19/2012WO2011044501A9 Antibacterial aminoglycoside analogs
04/19/2012WO2011036561A8 Process
04/19/2012US20120096569 Anti-il-6 antibodies,compositions, methods and uses
04/19/2012US20120095444 Polynucleotides encoding a human trim-cyp fusion polypeptide, compositions thereof, and methods of using same
04/19/2012US20120095277 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
04/19/2012US20120095116 Probe set for identification of nucleotide mutation, and method for identification of nucleotide mutation
04/19/2012US20120095093 Antifungal compounds
04/19/2012US20120095091 Antiepileptic, hypocholesterolemic and neuroprotective compound
04/19/2012US20120095083 Use of triplex structure dna in transferring nucleotide sequences
04/19/2012US20120095082 Use of interfering rna for treating an hiv infection
04/19/2012US20120095080 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
04/19/2012US20120095071 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
04/19/2012US20120095064 (pyrazol-3-yl)-1,3,4-thiadiazol-2-amine and (pyrazol-3-yl)-1,3,4-thiazol-2-amine compounds
04/19/2012US20120095058 Method of preventing survival of retrovirally cells and of inhibiting formation of infectious retroviruses
04/19/2012US20120095055 HEXAHYDROCYCLOPENTYL[f]INDAZOLE 5-HYDROXYMETHYL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
04/19/2012US20120095040 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof and therapeutic use thereof
04/19/2012US20120095022 Derivatives of 10-amino-1,2,3,4-tetrahydropyrido[2,1-a]isoindol-6(10bh)-ones, method for preparation thereof and therapeutic uses thereof
04/19/2012US20120095021 Synthsis of new benzothiazole derivatives as potential anti-tubercular agents
04/19/2012US20120095017 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
04/19/2012US20120094996 Imidazo [2, 1-B] [1, 3, 4] Thiadiazole Derivatives
04/19/2012US20120094987 SUBSTITUTED PYRIDO [3', 2': 4, 5] THIENO [3, 2-D] PYRIMIDINES AND PYRIDO [3', 2': 4, 5] FURO [3, 2-D] PYRIMIDINES USED AS INHIBITORS OF THE PDE-4 AND/OR THE RELEASE OF TNF-alpha
04/19/2012US20120094979 Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
04/19/2012US20120094976 New chemical compounds
04/19/2012US20120094975 Pyrido [5, 4-d] pyrimidines as cell proliferation inhibitors
04/19/2012US20120094970 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
04/19/2012US20120094962 Pharmaceutical composition for use in medical and veterinary ophthalmology
04/19/2012US20120094958 Quinolines as inhibitors of farnesyl pyrophosphate synthase
04/19/2012US20120094947 Method for the selective therapy of disease
04/19/2012US20120094939 Anti-viral compounds, compositions and methods
04/19/2012US20120094918 Method of using diketopiperazines and composition containing them
04/19/2012US20120094897 Novel inhibitors of hepatitis c virus replication
04/19/2012US20120094896 Inhibitors of viral integrase and methods of use
04/19/2012US20120094893 Method of using diketopiperazines and composition containing them
04/19/2012US20120094378 Nucleic acids encoding for antifungal bifunctional molecules for treating fungal infection
1 ... 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 ... 1798